Acetaldehyde - a major pathophysiologic factor in gastric

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Acetaldehyde - a major pathophysiologic factor in gastric carcinogenesis

Biohit Oyj Press Release 2.4.2015 at 9:30 a.m. local time (EEST)

Stomach cancer is the third leading cause of cancer death in both sexes worldwide (723,000 deaths/year, 8.8% of the total). The highest estimated mortality rates are in Eastern Asia. In a collaborative Japanese-Finnish study it was for the first time demonstrated that a genetic deficiency (ALDH2-deficiency) to eliminate acetaldehyde results in markedly increased (5.6-fold) exposure of the gastric mucosa to carcinogenic acetaldehyde after intragastric administration of alcohol.

When combined with earlier epidemiological findings, these results provide concrete evidence for the causal relationship of acetaldehyde not only with the pathogenesis of esophageal but also with gastric cancer. ALDH2-deficiency has been calculated to affect at least 540 million individuals with Eastern Asian roots. Thus, the carcinogenicity (Group 1/IARC/WHO) of acetaldehyde to humans is based on a unique human cancer model.

The highest stomach cancer risk is among ALDH2-deficient heavy drinkers whose stomach is anacidic due to atrophic gastritis. A recent meta-analysis suggests that the use of drugs suppressing gastric acid secretion is also associated with an increased risk of gastric cancer. A common pathogenetic denominator in both cases is acetaldehyde endogenously formed from alcohol. Acid free stomach is colonized with oral microbes, which together with mucosal cells produce locally acetaldehyde from alcohol. Acetaldehyde accumulates in gastric juice, because the capacity of mucosa and microbes to eliminate it is low.

Highest intragastric acetaldehyde concentrations were found in ALDH2-deficient individuals receiving a drug inhibiting gastric acid secretion. On the other hand, high gastric juice alcohol concentrations associated with high intragastric acetaldehyde levels, underlining the important role of alcoholic beverages in local acetaldehyde production. However, elevated gastric juice acetaldehyde levels were also found at low alcohol concentrations, corresponding to those of many foodstuffs and beverages produced by fermentation e.g. pickled food, soya sauces and dairy products.

The Acetium® capsule used in the study is a CE-marked product registered in many countries as a medical device (class IIa; patented and produced by Biohit Oyj, Helsinki, Finland). This classification is based on the nature of the active ingredient, L-cysteine, as a natural amino acid and the mode of the action of the formulation. Slowly from Acetium-capsule releasing L-cysteine binds acetaldehyde to a harmless compound in the stomach, where carcinogenic acetaldehyde is formed.  200mg of slow-release L-cysteine eliminated mean 60-67 % of gastric juice acetaldehyde in PPI-treated ALDH2-deficient and -active subjects, respectively and the effect lasted for two hours.

Cancer prevention is based on the identification of specific etiological factors. The exposure of the upper digestive tract to carcinogenic acetaldehyde can be decreased by many ways both at a population and individual level. Thus, the findings of the study provide entirely novel perspectives for the prevention of stomach cancer, especially among particular risk groups: those with ALDH2-deficiency, acid free stomach (atrophic gastritis), Helicobacter pylori infection, and regular use of prot o n pump inhibitors.

Invited comment: Professor of Internal Medicine, Gastroenterology and Alcohol Research, Helmut K. Seitz, University of Heidelberg: ‘The carcinogenicity of acetaldehyde is well established. However, this study shows for the first time its role in gastric cancer. The study demonstrates most convincingly that there is a high gastric acetaldehyde generation under certain conditions (ALDH2 deficiency, high gastric bacterial load) and there is a significant relationship between these conditions and the prevalence of stomach cancer. Thus, according to these data acetaldehyde is a major pathophysiologic factor in gastric carcinogenesis in certain individuals. Even more important, the authors demonstrate a preventive strategy by reducing gastric acetaldehyde.’

CEO Semi Korpela, Biohit Oyj: ‘Biohit Oyj has Acetium products and a way to reduce the amount of acetaldehyde (by binding it to a harmless compound). In addition to those with genetic inability to eliminate acetaldehyde, Acetium capsules are recommended as protection for those using inhibitors of gastric acid secretion (PPI-drugs), and to persons  suffering from an acid-free stomach (atrophic gastritis, identified by GastroPanel test) (see Additional Information). Acetium lozenges can be used to bind acetaldehyde into harmless compound in saliva in the mouth, which forms as a result of smoking and alcohol consumption. Biohit Oyj also has a patented method in e.g. Finland and USA, to bind acetaldehyde into harmless compound in alcoholic beverages and food products. In 2012, the European Commission's appointed group of scientific experts gave a unanimous recommendation stating that cosmetic products may contain acetaldehyde at most 5 mg/l while no acetaldehyde may be added to mouth wash. Many alcoholic beverages and foodstuffs sold in Finland exceed the maximum permitted amount for cosmetic products multiple times.’

Article in PLOS ONE database: http://dx.plos.org/10.1371/journal.pone.0120397

Attachment: Full article (pdf)

Attachment: Additional information (pdf)

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
De Beers Puts Namibia's 176-Carat Owishi on Display

Updated Category News Views 13

A 176-carat natural diamond can still make a room stop breathing, even in a trade battered by arguments over lab-grown supply, luxury spending, and what “rare” ought to mean anymore. De Beers Group, working with Grandview Klein Diamond, has unveiled Namibia’s Owishi natural diamond in Washington, DC. That is the hard fact on the table: a large Namibian stone, a U.S....

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 180

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 206

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Boat Market Forecast Puts Services in the Driver’s Seat

Updated Category News Views 51

A jet ski is not exactly a sober economic indicator, yet the water is telling a useful story. MarketsandMarkets projects the global recreational boat market will rise from $31.38 billion in 2026 to $48.06 billion in 2033, a 6.3% compound annual growth rate. That is respectable growth for a costly discretionary category that got knocked around by softer purchasing activity...

Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge

Updated Category News Views 182

Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...

Continue Reading
Medical School Rejections Carry a Steep Price Tag Too

Updated Category News Views 107

A rejection letter can turn into a remarkably expensive piece of paper. BeMo Academic Consulting's new Medical School Admissions Trends Report argues that the damage from missing medical-school admission goes far beyond bruised confidence: applicants can spend thousands chasing another cycle, lose time entering practice, and, if they never get in, forgo what the report...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 54

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
AES Clears FERC, Nearing Its December 2 Takeover Close

Updated Category News Views 131

One more regulatory gate just swung open for AES, and this deal is finally staring at the finish line instead of wandering through the usual approval swamp. The Federal Energy Regulatory Commission has issued its final order approving AES's acquisition by a consortium led by Global Infrastructure Partners, part of BlackRock, and EQT Infrastructure VI. The last major...

Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data

Updated Category News Views 152

Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...

Continue Reading

Top 5 Most Recently Viewed Articles

Delicious New Dips by Dean's Perfect for Every Snack Lovers

Updated Category News Views 536

Dean's Dip Launches Five Exciting New Flavors Dean's Dip, a well-loved name in the dairy dip sector, is thrilled to introduce its latest flavors, catering to snack aficionados everywhere. In addition to its classic offerings, the brand is now adding two delightful new dips — Creamy Dill and Jalapeño Popper. But that's not all! A fresh sub-line of dips, the Cantina...

Continue Reading
Bavarian Nordic Secures $63 Million for Vaccine Manufacturing

Updated Category News Views 102

Bavarian Nordic Secures New Contract with U.S. Government Bavarian Nordic A/S (Copenhagen: BAVA) has announced an important contract with the U.S. government's Biomedical Advanced Research and Development Authority (BARDA). This order, worth USD 63 million, will enhance the nation's stockpile of smallpox/mpox vaccines and pave the way for producing more freeze-dried doses...

Continue Reading
NewtekOne, Inc. Declares Impressive Quarterly Dividend Update

Updated Category News Views 158

NewtekOne, Inc. Announces Quarterly Dividend Declaration NewtekOne, Inc. (NASDAQ: NEWT) has recently made an exciting announcement for its shareholders. The Board of Directors has declared a quarterly cash dividend amounting to $0.19 per share, which is a testament to the company's ongoing commitment to enhancing shareholder value. As the company gears up for this...

Continue Reading
New Clean Freak Car Wash Location Welcomes Local Community

Updated Category News Views 516

Exciting New Location of Clean Freak Car Wash Clean Freak Car Wash, an innovative company supported by Circle K, is thrilled to announce the grand opening of its latest location. This highly anticipated launch is set to bring exceptional car wash services, designed to provide customers with a refreshing and satisfying experience. Commitment to Quality and Eco-Friendly...

Continue Reading
Bernie Sanders Calls for Action Against Wealth Inequality Surge

Updated Category News Views 200

Bernie Sanders Raises Concerns Over Wealth Disparity Sen. Bernie Sanders has openly criticized the increasing wealth inequality in the country, highlighting the significant gains of a select group of billionaires. His latest remarks reflect deep concern for the financial struggles faced by millions of Americans. Wealth of Billionaires on the Rise In a striking statement,...

Continue Reading